← Back to Search

Other

GAL1906 for Wrinkles

N/A
Waitlist Available
Research Sponsored by Q-Med AB
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks after initial injection
Awards & highlights

Study Summary

This trial will test how safe and effective GAL1906 is for reducing wrinkles on the chest. The trial is blinded, meaning the participants don't know which treatment they are receiving, and controlled, meaning there is a group receiving no treatment.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks after initial injection
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks after initial injection for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The percentage of responders on the Galderma Décolletage Scale, as assessed live by the Blinded Evaluator, at Week 12.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: GAL1906Experimental Treatment1 Intervention
Experimental product for correction of wrinkles
Group II: ControlActive Control1 Intervention
No treatment control
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
GAL1906
2021
N/A
~200

Find a Location

Who is running the clinical trial?

Q-Med ABLead Sponsor
80 Previous Clinical Trials
12,473 Total Patients Enrolled
1 Trials studying Wrinkles
110 Patients Enrolled for Wrinkles
Galderma R&DLead Sponsor
298 Previous Clinical Trials
60,138 Total Patients Enrolled
8 Trials studying Wrinkles
1,156 Patients Enrolled for Wrinkles

Media Library

GAL1906 (Other) Clinical Trial Eligibility Overview. Trial Name: NCT04717934 — N/A
Wrinkles Research Study Groups: GAL1906, Control
Wrinkles Clinical Trial 2023: GAL1906 Highlights & Side Effects. Trial Name: NCT04717934 — N/A
GAL1906 (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04717934 — N/A
Wrinkles Patient Testimony for trial: Trial Name: NCT04717934 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many locations in Canada are currently conducting this trial?

"This research project is being conducted at 11 sites located in Spring, Alpharetta, Birmingham and 8 additional locations. To reduce travel costs for participants it is beneficial to choose the nearest site if you decide to join this trial."

Answered by AI

Are there any open slots available for this experiment?

"According to the clinicaltrials.gov, this particular trial is no longer being promoted for patient recruitment and was last updated on September 6th 2022. However, 20 other trials are currently recruiting patients at this time."

Answered by AI

Who else is applying?

What state do they live in?
Georgia
Texas
Indiana
Other
How old are they?
18 - 65
What site did they apply to?
Galderma Research Site
Other
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
1
0

What questions have other patients asked about this trial?

How long does the screening take? How long is the trial and how many visits?
PatientReceived 2+ prior treatments

Why did patients apply to this trial?

I have used creams and moisturizers for over 10 years to prevent further wrinkling but nothing has been effective.
PatientReceived 1 prior treatment
~46 spots leftby Apr 2025